# SCMH1

## Overview
SCMH1 is a gene that encodes the Scm polycomb group protein homolog 1, a member of the polycomb group (PcG) proteins involved in chromatin remodeling and gene expression regulation. The protein plays a critical role in maintaining transcriptional repression of genes, particularly during development, by being a component of the Polycomb Repressive Complex 1 (PRC1). This complex is essential for modifying histones and influencing gene expression patterns necessary for cell differentiation and development. SCMH1 is characterized by conserved domains, such as the SPM domain, which facilitate its interactions with other PcG proteins, thereby contributing to its function in chromatin remodeling. The protein's activity is modulated by post-translational modifications and exists in multiple splice variant isoforms, which may affect its structural and functional properties. SCMH1's involvement in chromatin assembly and regulation of homeotic genes underscores its importance in developmental processes and cellular homeostasis (Tomotsune1999A; Tripaldi2013Human; Wu2008Adaptive).

## Structure
SCMH1 (Scm polycomb group protein homolog 1) is a protein involved in chromatin remodeling and gene expression regulation. It is a member of the polycomb group (PcG) proteins, which are essential for maintaining the transcriptional repression of genes. SCMH1 contains several conserved domains, including the SPM domain, which plays a critical role in protein-protein interactions. This domain is integral to the protein's function in forming complexes with other PcG proteins, facilitating its role in chromatin remodeling.

The protein may undergo post-translational modifications such as phosphorylation, which can influence its function and interactions. These modifications are crucial for the dynamic regulation of SCMH1 activity and its ability to participate in various cellular processes. SCMH1 can exist in multiple splice variant isoforms, which may affect its structural and functional properties. These isoforms can lead to variations in the protein's interaction capabilities and its role in gene repression.

While specific details on the primary, secondary, tertiary, and quaternary structures of SCMH1 are not provided, the presence of conserved domains like the SPM domain suggests a complex structure that supports its functional roles in chromatin remodeling and gene expression regulation.

## Function
SCMH1 (Scm polycomb group protein homolog 1) is a component of the Polycomb Repressive Complex 1 (PRC1), which plays a crucial role in chromatin remodeling and gene silencing. This protein is involved in maintaining the transcriptional repression of genes during development by modifying histones, thereby influencing gene expression patterns essential for cell differentiation and development (Wu2008Adaptive). SCMH1 is expressed at relatively high levels in smooth muscle cells, interstitial cells of Cajal, and PDGFRα cells within the SIP syncytium, suggesting its involvement in transcriptional regulation within these cell types (Schneider2022Single).

SCMH1 is implicated in chromatin assembly, indicating its role in chromatin-related processes (Tripaldi2013Human). It is also associated with the regulation of homeotic genes during embryogenesis, highlighting its importance in developmental processes (Wu2008Adaptive). While the specific function of SCMH1 in healthy human cells is not fully detailed, its involvement in these fundamental cellular processes suggests a significant role in maintaining cellular and organismal homeostasis. The protein's activity in the cell is primarily linked to its function as part of the PRC1 complex, contributing to the repression of target genes through chromatin modification.

## Clinical Significance
Alterations in the expression of the SCMH1 gene, particularly in its circular RNA form circSCMH1, have been implicated in various diseases. In ischemic stroke, circSCMH1 levels are significantly decreased in patients and animal models, suggesting its potential role in stroke recovery. The therapeutic delivery of circSCMH1 using engineered extracellular vesicles has shown promise in improving functional recovery by enhancing neuronal plasticity and reducing glial activation and immune cell infiltration (Yang2020Extracellular).

In contrast, circSCMH1 is upregulated in oral squamous cell carcinoma (OSCC), particularly in cases resistant to the chemotherapy drug cisplatin (DDP). This upregulation is associated with higher TNM grade and lymph node metastasis. CircSCMH1 contributes to DDP resistance by acting as a molecular sponge for miR-338-3p, which regulates the expression of LIN28B, a gene linked to OSCC progression. Targeting circSCMH1 to suppress its expression has been shown to reduce chemoresistance, decrease tumor growth, and promote apoptosis in OSCC cells (Qiu2021Blocking).

These findings highlight the dual role of circSCMH1 in different pathological contexts, suggesting its potential as both a therapeutic target and a biomarker for disease prognosis and treatment response.

## Interactions
SCMH1, a member of the Polycomb group (PcG) proteins, is involved in various protein interactions that contribute to its role in chromatin remodeling and gene regulation. SCMH1 interacts with the SPM domain of RAE28/mph1, another PcG protein, suggesting a potential in vivo interaction that is supported by their overlapping expression patterns during embryogenesis (Tomotsune1999A). This interaction is crucial for the regulation of homeotic genes during embryogenesis (Tomotsune1999A).

SCMH1 is also part of the Polycomb Repressive Complex 1 (PRC1), where it interacts with other PcG proteins such as BMI1. This interaction is significant in mediating neuroprotection and ischemic tolerance by regulating the expression of potassium channel genes (Stapels2010Polycomb). SCMH1 and BMI1 bind to the promoter regions of potassium channel genes like Kcna5 and Kcnab2, influencing their expression and contributing to ischemic tolerance (Stapels2010Polycomb).

Additionally, SCMH1 interacts with SCML2A, another PcG protein, through their C-terminal SPM domains. This interaction is part of the broader network of PcG protein interactions that contribute to chromatin repression and gene silencing (Bonasio2014Interactions).


## References


[1. (Yang2020Extracellular) Li Yang, Bing Han, Zhiting Zhang, Shuguo Wang, Ying Bai, Yuan Zhang, Ying Tang, Lingli Du, Ling Xu, Fangfang Wu, Lei Zuo, Xufeng Chen, Yu Lin, Kezhong Liu, Qingqing Ye, Biling Chen, Bin Li, Tianci Tang, Yu Wang, Ling Shen, Guangtian Wang, Minzi Ju, Mengqin Yuan, Wei Jiang, John H. Zhang, Gang Hu, Jianhong Wang, and Honghong Yao. Extracellular vesicle–mediated delivery of circular rna scmh1 promotes functional recovery in rodent and nonhuman primate ischemic stroke models. Circulation, 142(6):556–574, August 2020. URL: http://dx.doi.org/10.1161/CIRCULATIONAHA.120.045765, doi:10.1161/circulationaha.120.045765. This article has 262 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1161/CIRCULATIONAHA.120.045765)

[2. (Bonasio2014Interactions) Roberto Bonasio, Emilio Lecona, Varun Narendra, Philipp Voigt, Fabio Parisi, Yuval Kluger, and Danny Reinberg. Interactions with rna direct the polycomb group protein scml2 to chromatin where it represses target genes. eLife, July 2014. URL: http://dx.doi.org/10.7554/elife.02637, doi:10.7554/elife.02637. This article has 41 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7554/elife.02637)

[3. (Wu2008Adaptive) Hai-hui Wu and Bing Su. Adaptive evolution of scml1 in primates, a gene involved in male reproduction. BMC Evolutionary Biology, 8(1):192, 2008. URL: http://dx.doi.org/10.1186/1471-2148-8-192, doi:10.1186/1471-2148-8-192. This article has 10 citations.](https://doi.org/10.1186/1471-2148-8-192)

[4. (Tomotsune1999A) Daihachiro Tomotsune, Yoshihiro Takihara, Joel Berger, David Duhl, Sunghae Joo, Michael Kyba, Manabu Shirai, Hideaki Ohta, Yoichi Matsuda, Barry M. Honda, Jeffrey Simon, Kazunori Shimada, Hugh W. Brock, and Filippo Randazzo. A novel member of murine polycomb-group proteins, sex comb on midleg homolog protein, is highly conserved, and interacts with rae28/mph1 in vitro. Differentiation, 65(4):229–239, December 1999. URL: http://dx.doi.org/10.1046/j.1432-0436.1999.6540229.x, doi:10.1046/j.1432-0436.1999.6540229.x. This article has 32 citations and is from a peer-reviewed journal.](https://doi.org/10.1046/j.1432-0436.1999.6540229.x)

[5. (Tripaldi2013Human) Romina Tripaldi, Liborio Stuppia, and Saverio Alberti. Human height genes and cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1836(1):27–41, August 2013. URL: http://dx.doi.org/10.1016/j.bbcan.2013.02.002, doi:10.1016/j.bbcan.2013.02.002. This article has 11 citations.](https://doi.org/10.1016/j.bbcan.2013.02.002)

6. (Schneider2022Single) Single Nucleus Sequencing of Human Colon Visceral Smooth Muscle Cells, PDGFRα Cells, and Interstitial Cells of Cajal. This article has 0 citations.

[7. (Stapels2010Polycomb) Martha Stapels, Chelsea Piper, Tao Yang, Minghua Li, Cheri Stowell, Zhi-gang Xiong, Julie Saugstad, Roger P. Simon, Scott Geromanos, James Langridge, Jing-quan Lan, and An Zhou. Polycomb group proteins as epigenetic mediators of neuroprotection in ischemic tolerance. Science Signaling, March 2010. URL: http://dx.doi.org/10.1126/scisignal.2000502, doi:10.1126/scisignal.2000502. This article has 86 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1126/scisignal.2000502)

[8. (Qiu2021Blocking) Feng Qiu, Bin Qiao, Nan Zhang, Zheng Fang, Lu Feng, Shanfeng Zhang, and Weiliu Qiu. Blocking circ-scmh1 (hsa_circ_0011946) suppresses acquired ddp resistance of oral squamous cell carcinoma (oscc) cells both in vitro and in vivo by sponging mir-338-3p and regulating lin28b. Cancer Cell International, August 2021. URL: http://dx.doi.org/10.1186/s12935-021-02110-8, doi:10.1186/s12935-021-02110-8. This article has 23 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12935-021-02110-8)